ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Bavituximab Biosimilar - Anti-PISD Antibody - Low endotoxin, Azide free (A323304)

Recombinant chimeric monoclonal antibody to PISD for ELISA, FACS, Functional Assay and In Vivo.

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 12-18 business days.
Name
Bavituximab Biosimilar - Anti-PISD Antibody - Low endotoxin, Azide free
Description
Recombinant chimeric monoclonal antibody to PISD.
Applications
ELISA, FACS, Functional Assay, In Vivo
Reactivity
Human, Mouse, Cynomolgus Macaque
Host
Mouse / Human
Clonality
Monoclonal
Isotype
IgG1
Light Chains
kappa
Conjugate

Unconjugated

Purification
Protein A affinity chromatography.
Concentration
Reconstitution dependent.
Molecular Weight
This antibody has a predicted MW of 145.3 kDa.
Purity
> 95% (by SDS-PAGE and SEC-HPLC).
Product Form
Lyophilized
Reconstitution
Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!
Formulation
Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.
Storage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
Synonyms
Phosphatidylserine decarboxylase proenzyme, mitochondrial
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Bavituximab Biosimilar - Anti-PISD Antibody - Low endotoxin, Azide free (A323304)? Please let us know so that we can list the citation on this page.

Alternative products to Bavituximab Biosimilar - Anti-PISD Antibody - Low endotoxin, Azide free (A323304)

Proteins predicted to interact with PISD

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
98.6% Relevancy Score
98.5% Relevancy Score
97.4% Relevancy Score
97.1% Relevancy Score
92.5% Relevancy Score
92.2% Relevancy Score
91.7% Relevancy Score
91.1% Relevancy Score
90.6% Relevancy Score